Read our latest advice on Coronavirus (COVID-19)

Our services are open and safe to attend – we are here to help

Urticaria research



Coronavirus: dermatology update

In response to the coronavirus (COVID-19) outbreak, please read our advice and information.

Our research

Recent and ongoing research projects include trials of a new anti-IgE biologic for chronic spontaneous urticaria (ligelizumab), a topical mast cell inhibitor cream and a study of KIT mutations in peripheral blood of children.

Multicentre studies for novel treatments in chronic urticaria and mastocytosis are planned for 2019.

Find out more about our open and completed clinical trials





There are a number of studies currently open actively looking for recruits.

For more information about our trials or if you are interested in taking part, please email dermatologytrials@


I would definitely recommend taking part in research… new
treatments need patient involvement and I wanted to help others in the

Jane Johnston, a participant in one of our clinical trials